Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 2
2008 3
2009 2
2010 1
2012 2
2014 1
2017 4
2020 1
2021 1
2022 2
2023 2
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.
EVOLVE Trial Investigators; Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS. EVOLVE Trial Investigators, et al. N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121374 Free article. Clinical Trial.
Growth differentiation factor-15 predicts major bleeding, major adverse cardiac events and mortality in patients with end-stage kidney disease on haemodialysis: findings from the VIVALDI study.
Nopp S, Königsbrügge O, Schmaldienst S, Klauser-Braun R, Lorenz M, Pabinger I, Säemann M, Ay C. Nopp S, et al. Among authors: klauser braun r. Nephrol Dial Transplant. 2023 Jul 31;38(8):1836-1847. doi: 10.1093/ndt/gfac321. Nephrol Dial Transplant. 2023. PMID: 36472548
Anticoagulation use and the risk of stroke and major bleeding in patients on hemodialysis: From the VIVALDI, a population-based prospective cohort study.
Königsbrügge O, Meisel H, Beyer A, Schmaldienst S, Klauser-Braun R, Lorenz M, Auinger M, Kletzmayr J, Hecking M, Winkelmayer WC, Lang I, Pabinger I, Säemann M, Ay C. Königsbrügge O, et al. Among authors: klauser braun r. J Thromb Haemost. 2021 Dec;19(12):2984-2996. doi: 10.1111/jth.15508. Epub 2021 Sep 5. J Thromb Haemost. 2021. PMID: 34418291 Free article.
Antithrombotic agents for primary and secondary prevention of cardiovascular events in patients with end-stage renal disease on chronic hemodialysis.
Königsbrügge O, Schmaldienst S, Auinger M, Klauser-Braun R, Lorenz M, Tabernig S, Kletzmayr J, Enzenberger B, Eigner M, Hecking M, Siller-Matula JM, Pabinger I, Säemann M, Ay C. Königsbrügge O, et al. Among authors: klauser braun r. Atherosclerosis. 2020 Apr;298:1-6. doi: 10.1016/j.atherosclerosis.2020.02.011. Epub 2020 Feb 16. Atherosclerosis. 2020. PMID: 32126388
Elevated uric acid increases the risk for kidney disease.
Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R. Obermayr RP, et al. Among authors: klauser braun r. J Am Soc Nephrol. 2008 Dec;19(12):2407-13. doi: 10.1681/ASN.2008010080. Epub 2008 Sep 17. J Am Soc Nephrol. 2008. PMID: 18799720 Free PMC article.
21 results